Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries

Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States

(2015) Zobair M. Younossi et al.   HEPATOLOGY

Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials

(2015) Zobair M. Younossi et al.   HEPATOLOGY

The Changing Burden of Hepatitis C Virus Infection in the United States: Model-Based Predictions

(2014) Mina Kabiri et al.   ANNALS OF INTERNAL MEDICINE

Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens

(2014) Zobair M. Younossi et al.   HEPATOLOGY

Global distribution and prevalence of hepatitis C virus genotypes

(2014) Jane P. Messina et al.   HEPATOLOGY

Hepatitis C and Work Impairment

(2014) Vignan Manne et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Global epidemiology and genotype distribution of the hepatitis C virus infection

(2014) Erin Gower et al.   JOURNAL OF HEPATOLOGY

Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study

(2014) Zobair M. Younossi et al.   JOURNAL OF HEPATOLOGY

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

(2014) H. Razavi et al.   JOURNAL OF VIRAL HEPATITIS

Work productivity among treatment-naïve patients with genotype 1 chronic hepatitis C infection receiving telaprevir combination treatment

(2014) J. Aggarwal et al.   JOURNAL OF VIRAL HEPATITIS

Historical epidemiology of hepatitis C virus (HCV) in selected countries

(2014) P. Bruggmann et al.   JOURNAL OF VIRAL HEPATITIS

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

(2014) Kris V. Kowdley et al.   NEW ENGLAND JOURNAL OF MEDICINE

The burden of hepatitis C in Europe from the patients’ perspective: a survey in 5 countries

(2013) Jeffrey Vietri et al.   BMC GASTROENTEROLOGY

Socioeconomic status in HCV infected patients – risk and prognosis

(2013) Lars Haukali Omland et al.   Clinical Epidemiology

The Burden of Untreated Hepatitis C Virus Infection: A US Patients’ Perspective

(2012) Antoine C. El Khoury et al.   DIGESTIVE DISEASES AND SCIENCES

The burden of viral hepatitis C in Europe

(2012) Marco daCosta DiBonaventura et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

(2012) Khayriyyah Mohd Hanafiah et al.   HEPATOLOGY

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

(2011) Markus Cornberg et al.   LIVER INTERNATIONAL

The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities

(2011) Marco daCosta DiBonaventura et al.   JOURNAL OF MEDICAL ECONOMICS

Manifestations of Chronic Hepatitis C Virus Infection Beyond the Liver

(2010) Ira M. Jacobson et al.   Clinical Gastroenterology and Hepatology

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality

(2009) Nikolai Mühlberger et al.   BMC PUBLIC HEALTH